10 found
Order:
  1.  17
    Ban the Sunset? Nonpropositional Content and Regulation of Pharmaceutical Advertising.Paul Biegler & Patrick Vargas - 2013 - American Journal of Bioethics 13 (5):3-13.
    The risk that direct-to-consumer advertising of prescription pharmaceuticals (DTCA) may increase inappropriate medicine use is well recognized. The U.S. Food and Drug Administration addresses this concern by subjecting DTCA content to strict scrutiny. Its strictures are, however, heavily focused on the explicit claims made in commercials, what we term their ?propositional content.? Yet research in social psychology suggests advertising employs techniques to influence viewers via nonpropositional content, for example, images and music. We argue that one such technique, evaluative conditioning, is (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   9 citations  
  2.  1
    Response to Open Peer Commentaries on “Ban the Sunset? Nonpropositional Content and Regulation of Pharmaceutical Advertising”.Paul Biegler & Patrick Vargas - 2013 - American Journal of Bioethics 13 (5):W1 - W5.
    Direct download (4 more)  
     
    Export citation  
     
    My bibliography   5 citations  
  3.  12
    Ethics of Implicit Persuasion in Pharmaceutical Advertising.Paul Biegler, Jeanette Kennett, Justin Oakley & Patrick Vargas - unknown
    Direct download  
     
    Export citation  
     
    My bibliography   1 citation  
  4.  42
    Autonomy and Ethical Treatment in Depression.Paul Biegler - 2010 - Bioethics 24 (4):179-189.
    Antidepressant medication and evidence-based psychotherapy have largely equivalent efficacy in the management of the common, less severe grades of depression. As a result, several national guidelines recommend that either can be used in the treatment of this disorder. Psychotherapy, however, differs in that it assists insight into how the depressed person appraises and manages the stressors that frequently trigger depressive episodes. I argue that the self-knowledge achieved through psychotherapy has moral value in that it promotes the autonomy of stressor-related decisions. (...)
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  5.  3
    The Ethical Treatment of Depression: Autonomy Through Psychotherapy.Paul Biegler - unknown
    Direct download  
     
    Export citation  
     
    My bibliography   1 citation  
  6.  9
    Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.Paul Biegler & Patrick Vargas - 2016 - Journal of Bioethical Inquiry 13 (2):271-279.
    A central goal in regulating direct-to-consumer advertising of prescription pharmaceuticals is to ensure that explicit drug claims are truthful. Yet imagery can also alter viewer attitudes, and the degree to which this occurs in DTCA is uncertain. Addressing this data gap, we provide evidence that positive feelings produced by images can promote favourable beliefs about pharmaceuticals. We had participants view a fictitious anti-influenza drug paired with unrelated images that elicited either positive, neutral or negative feelings. Participants who viewed positive images (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  7.  12
    Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising.Paul Biegler - 2015 - Kennedy Institute of Ethics Journal 25 (2):193-230.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  8.  3
    Placebogenic Potential is No Reason to Favour Pharmaceutical Advertising.Paul Biegler - 2013 - Journal of Business Ethics 123 (1):1-11.
    Advertisements for pharmaceuticals may promote placebo responses by generating an expectation of therapeutic success. Some cite this as reason to favour Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA). Against this, I show placebo responses to emanate from beliefs rendered unjustified by the influence of a conditioning process. I argue that drug safety and efficacy are material properties and that unjustified beliefs in these domains entail costs to autonomy that outweigh any prudential gains attending a placebo response. I conclude that (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  9.  2
    In Defence of Mandatory Bicycle Helmet Legislation: Response to Hooper and Spicer.Paul Biegler & Marilyn Johnson - 2015 - Journal of Medical Ethics 41 (8):713-717.
    We invoke a triple rationale to rebut Hooper and Spicer's argument against mandatory helmet laws. First, we use the laws of physics and empirical studies to show how bicycle helmets afford substantial protection to the user. We show that Hooper and Spicer erroneously downplay helmet utility and that, as a result, their attack on the utilitarian argument for mandatory helmet laws is weakened. Next, we refute their claim that helmet legislation comprises unjustified paternalism. We show the healthcare costs of bareheaded (...)
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography  
  10. Climate of Disbelief.Paul Biegler - 2014 - Philosophy Now 103:15-17.